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 1 
Does therapy with biofeedback improve swallowing in adults with dysphagia? A 1 
systematic review and meta-analysis 2 
 3 
ABSTRACT 4 
Objective: To describe and systematically review the current evidence on the effects of 5 
swallow therapy augmented by biofeedback in adults with dysphagia (PROSPERO 6 
2016:CRD42016052942).  7 
Data sources: Two independent reviewers conducted searches which included MEDLINE, 8 
EMBASE, trial registries and grey literature up to December 2016.  9 
Study selection: Randomised controlled trials (RCTs) and non-RCTs were assessed, 10 
including for risk of bias and quality.  11 
Data extraction: Data were extracted by one reviewer and verified by another on 12 
biofeedback type, measures of swallow function, physiology and clinical outcome, and 13 
analysed using Cochrane Review Manager (random effects models). Results are expressed 14 
as weighted mean difference (WMD) and odds ratio (OR). 15 
Data Synthesis: Of 675 articles, we included 23 studies (n=448 participants). Three main 16 
types of biofeedback were used: accelerometry, surface electromyography and tongue 17 
manometry. Exercises included saliva swallows, manoeuvres and strength exercises. Dose 18 
varied between 6-72 sessions for 20-60 minutes. Five controlled studies (stroke n=95; head 19 
and neck cancer n=33; mixed aetiology n=10) were included in meta-analyses. Compared to 20 
control, biofeedback augmented dysphagia therapy significantly enhanced hyoid 21 
displacement (three studies, WMD=0.22cm; 95% CI [0.04, 0.40], p=0.02) but there was no 22 
significant difference in functional oral intake (WMD=1.10; 95%CI [-1.69, 3.89], p=0.44) or 23 
dependency on tube feeding (OR =3.19; 95%CI [0.16, 62.72], p=0.45). Risk of bias was high 24 
and there was significant statistical heterogeneity between trials in measures of swallow 25 
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function and number tube fed (I2 70-94%). Several non-validated outcome measures were 26 
used. Subgroup analyses were not possible due to a paucity of studies. 27 
Conclusions: Dysphagia therapy augmented by biofeedback using surface 28 
electromyography and accelerometry enhances hyoid displacement but functional 29 
improvements in swallowing are not evident. However data are extremely limited and further 30 
larger well-designed RCTs are warranted.  31 
Key words: Biofeedback, dysphagia, rehabilitation 32 
 33 
Dysphagia is increasingly common in an aging population with reports of symptoms 34 
occurring in 40% of adults over 65.1 Prevalence of dysphagia varies according to aetiology; 35 
55 % of stroke patients,2 11–81 % in Parkinson’s disease,3 11-93.5% in head and neck 36 
cancer 4 and more than 90% of patients with motor neurone disease.5 Dysphagia can cause 37 
complications such as aspiration pneumonia, dehydration and malnutrition and lead to 38 
increased mortality.6-8 Early assessment, tube feeding, texture modification and adaptive 39 
strategies can reduce these risks 9-11 but can impact on quality of life.12 40 
 41 
Therapeutic interventions which aim to maintain or rehabilitate swallowing vary from muscle 42 
strengthening exercises, swallow skill exercises, sensory stimulation and emerging 43 
techniques such as peripheral and central stimulation.13 Feedback is advocated for 44 
enhancing outcomes in rehabilitation.14 Error-based learning where the learner has 45 
knowledge of the errors they need to correct, can aid learning or re-learning a skill.15 When 46 
this information about performance is given based on kinematic measures it is called 47 
biofeedback. 48 
 49 
In post stroke upper limb therapy, performance feedback enhances motor recovery.16 50 
Further, biofeedback has resulted in moderate to large treatment effects in gait when 51 
compared to usual therapy17 and has been shown to be beneficial with other physical, 52 
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psychological, cardiac and respiratory conditions;18 for example, using a decibel meter has 53 
been widely used in speech therapy, for increasing voice volume and quality in patients with 54 
Parkinson’s disease.19 During swallowing, intrinsic feedback is acquired from sensation 55 
within the oral cavity and pharynx, but it may be suboptimal or impaired in patients with 56 
dysphagia. There is a progressive reduction in pharyngeal and laryngeal sensation with 57 
increasing age 20 and sensory impairments can be one of the characteristics of dysphagia in 58 
many aetiologies.21-24 Making accurate judgements about subtle differences in the efficacy of 59 
the pharyngeal stage of swallowing is difficult without instrumental measurements.25  60 
 61 
Biofeedback in swallowing therapy is not routinely used to augment dysphagia therapy 26 nor 62 
is there national recognition and guidance regarding its use. However, it is gaining more 63 
interest and several commercially available biofeedback instruments and software are on the 64 
market and so there is a need to evaluate its effectiveness. We performed a systematic 65 
review and meta-analysis to describe the current evidence on the effects of dysphagia 66 
therapy with all types of biofeedback in adults with dysphagia in order to discover the most 67 
superior methods.  68 
 69 
METHODS 70 
This review aimed to answer the following questions in adults with dysphagia: Does 71 
biofeedback paired with dysphagia therapy, as compared with no biofeedback, improve (1) 72 
Functional swallowing outcomes? (2) Clinical outcomes? (3) Swallow physiology? 73 
 74 
The protocol was registered with Prospero (2016:CRD42016052942) in December 2016. 75 
Studies were eligible for inclusion if they were full text, English language studies that 76 
involved dysphagia therapy using biofeedback in adults with any aetiology resulting in 77 
acquired oropharyngeal dysphagia and reported pre- and post-swallowing measures and/or 78 
clinical outcomes. Two independent reviewers conducted electronic searches from when 79 
records began until December 2016 of the following databases: Cochrane Stroke Group 80 
Dysphagia biofeedback SR & MA CONFIDENTIAL  16th April 2018 
 4 
Trials Register, MEDLINE, EMBASE, CINAHL, Conference Proceedings Citation Index- 81 
Science (CPCI-S) and Web of Science.  Reviews of reference lists, conference abstracts 82 
and internet searches were conducted to ensure inclusion of unpublished or ongoing trials. 83 
Authors were contacted where partial or incomplete data were not available. An example of 84 
the search strategy for the MEDLINE search is included in Figure 1.  85 
 86 
Study selection 87 
Two reviewers (JB and LE) searched the title and abstracts of the studies and excluded 88 
those that were not relevant. If there were any doubts the full text was sought. Once the full 89 
text was obtained the same reviewers selected the relevant studies for (1) A descriptive 90 
analysis of the types and application of biofeedback used in dysphagia therapy, and (2) 91 
Those meeting criteria for inclusion in a meta-analysis. Any disagreements were resolved 92 
with a third reviewer TE. Only those with a non-confounded control group and outcome data 93 
were included in the meta-analysis.  94 
 95 
Data acquisition  96 
Data were extracted using a predesigned and piloted proforma by one reviewer, JB and then 97 
verified by a second reviewer, LE.  Authors were contacted if data were not available. TE 98 
resolved any discrepancies.  99 
 100 
Risk of bias  101 
Randomised control trials (RCTs) were assessed for risk of bias and quality as 102 
recommended in the Cochrane Handbook.27 This included assessing methods of 103 
randomisation, allocation concealment, blinding of participants and personnel, blinding of 104 
outcome assessment, incomplete outcome data and selective outcome reporting.  Non 105 
RCTs were assessed using a combination of different tools for non RCTs and observational 106 
studies 28-30 and included assessing quality of study designs for small N and N=1 studies, 107 
data analysis, generalisability, replicability, blinding, incomplete and selective reporting. 108 
Dysphagia biofeedback SR & MA CONFIDENTIAL  16th April 2018 
 5 
 109 
Statistical analysis  110 
Review Manager (version 5.3) was used to derive odds ratios (OR) and confidence intervals 111 
(CIs) for dichotomous data and mean difference (MD) and CIs for continuous data. Study 112 
data were combined if the outcome measures used were comparable. In the Aoki 2015 113 
study the mean and standard deviation (SD) were estimated from the median and range 114 
using published formulae 31. Heterogeneity was assessed between different studies for each 115 
measure. Sub-group analysis was planned to examine whether biofeedback type, dose, 116 
aetiology of dysphagia or setting made a difference to outcome.   117 
 118 
RESULTS 119 
Initial searches identified 669 articles, and a further 6 were found through searching grey 120 
literature. After screening titles and abstracts, full text was sought for 53 studies. One full text 121 
article could not be obtained but there was sufficient detail in the abstract to be included in 122 
our analysis. 32 Of those, 23 were suitable for inclusion in a qualitative synthesis and 5 met 123 
the criteria for inclusion in the meta-analysis (Table 1, Figure 2). 124 
 125 
Study characteristics  126 
Twenty-three studies (n=448 participants) described dysphagia interventions with 127 
biofeedback in adults with structural, neurological and psychological dysphagia (Table 1). 128 
The three main types of biofeedback used were surface electromyography (sEMG, n=164), 129 
accelerometry (n=150) and tongue manometry (n=67). Less frequent forms of biofeedback 130 
included videoendoscopy (n=33), respiratory plethysmography (n=30) and external laryngeal 131 
manometry (n=4).  There was no type of biofeedback exclusive to a specific patient group. 132 
Dosing and frequency of therapy varied across studies and across types of biofeedback; 133 
from 4 to 72 sessions carried out twice daily to fortnightly.33-36 Over 80% of studies reported 134 
2 or more sessions per week. Overall, treatment sessions varied in length across study and 135 
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type of biofeedback and lasted between 20-60 minutes with 45-60 minutes being the most 136 
common (50%).  137 
 138 
Accelerometry  139 
Five studies used accelerometry as a means of biofeedback. This consists of a small 140 
accelerometer being placed just above the thyroid cartilage. It measures the epidermal 141 
vibrations caused by the internal sounds and vibrations of the superior/inferior and or 142 
anterior/posterior movements of the hyoid and larynx during swallowing.37 The vibrations are 143 
converted into a voltage signal, which the patient can use as visual feedback to facilitate 144 
their swallowing therapy. In three of the studies, feedback was presented as a graph on a 145 
computer screen with instruction to match the shape of a signal derived from a normal 146 
swallow.38-40 In one study, the signal from the accelerometer was converted into an 147 
animation of a frog swallowing a mosquito at different locations on a screen. 41 The target 148 
was adjusted based on performance. Another study used signals from accelerometry and 149 
surface electromyography (sEMG) in a similar virtual reality game.42 Only one of these 150 
studies had a control group, 41 which reported that accelerometry significantly improved 151 
functional intake (functional oral intake scale, FOIS, p=0.014) and hyoid displacement 152 
(p=0.07) compared to control which received the same intensity of exercise without 153 
biofeedback. The other four accelerometry studies were of lower quality and also reported 154 
functional improvements in swallowing following the therapy.   155 
 156 
Tongue manometry  157 
Five studies used tongue manometry for biofeedback.33, 43-46 This intervention consists of 158 
using a 2cm x 1cm x 0.5 cm air filled pressure bulb which acts as a pneumatic pressure 159 
sensor and measures isometric tongue strength. The bulb is placed on the tongue and the 160 
participant is instructed to push the tongue against the hard palate. The pressure generated 161 
is measured by a manometer and the signal can be displayed graphically on a screen to 162 
give patients biofeedback. Four studies used the Iowa Oral Performance Instrument (IOPI) 163 
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33, 43, 45, 46 and one used a Japanese version manufactured by Japan Medical Supply Ltd 164 
(JMS).44  Robbins and colleagues used isometric anterior and posterior tongue strength 165 
exercises with the aim of increasing muscle strength and mass to lead to improvements in 166 
functional swallow.33 The other four studies used isometric tongue strengthening, tongue 167 
strength accuracy exercises and tongue strength during saliva swallow exercises.43-46 One 168 
study used a control group which received tongue exercises without biofeedback at the 169 
same intensity.44 They described significant differences in mean change between treatment 170 
and control groups on maximum isometric pressure (p=0.03), swallowing tongue pressures 171 
(p=0.014) and motor function of swallowing structures – Mann Assessment of Swallowing 172 
Ability (MASA) (p=0.04), but no significant differences between groups on swallow function.  173 
Four other studies of poor design reported positive outcomes in tongue strength33, 43, 45, 46 . 174 
Moreover, reductions in vallecular45 and pharyngeal wall residue33 were observed on 175 
videofluoroscopy but the findings are contradicted in other studies where residue scores 176 
were neutral33 or worse43.  Only one of the studies described a positive functional swallowing 177 
outcome, 33 but no recognisable or specific outcome measures were presented. 178 
 179 
Surface Laryngeal Manometry  180 
One study used an air-filled balloon fixed externally to the cervical region to measure 181 
changes in pressure during swallowing.47 Participants practised an effortful swallow and 182 
were given numerical feedback about their performance. It was a small study and there was 183 
no control group but the 4 patients with dysphagia secondary to Parkinson’s reported 184 
improvements in swallow function following the intervention.   185 
 186 
Surface Electromyography (sEMG)  187 
Ten studies used sEMG as a means of providing biofeedback. sEMG measures the spatial 188 
and temporal properties of muscle action potentials. The amplitude of the signal increases 189 
with increased force of muscle contraction.48 In 9 of 10 studies, sEMG was used to measure 190 
the activity of the muscles which elevate and tilt the larynx during the pharyngeal swallow 191 
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(the remaining study utilised sEMG in a patient with psychogenic dysphagia).49 Two small 192 
electrodes are placed on the submental muscles (mylohyoid, geniohyoid, anterior belly of 193 
digastric and genioglossus) and a third reference electrode is usually placed to one side.50 194 
The sEMG signal represents the timing and force of the muscle contraction and is displayed 195 
graphically on a screen. sEMG has been employed using a variety of strategies, such as 196 
providing progressively more challenging targets based on strength and timing;51 and 197 
enhancing the design of a swallow protocol helping the participant with timing of muscle 198 
contraction and respiratory patterns.52 The remaining studies used biofeedback to teach and 199 
practice either or both effortful swallow and the Mendelsohn manoeuvre (holding the larynx 200 
elevated for a target number of seconds).34, 36, 50, 53-56 Two studies met the criteria to be 201 
included in a meta-analysis. McCullough et al used sEMG biofeedback to teach and practice 202 
the Mendelsohn manoeuvre to patients who had dysphagia secondary to stroke. The data 203 
was reported in two papers,34, 57 demonstrating significant improvements in duration of hyoid 204 
elevation (p=0.011) and anterior hyoid movement (p=0.009) but no other physiological or 205 
functional changes were found. Huimin et al provided swallow function training with 206 
biofeedback compared to swallow function training without biofeedback and reported 207 
significant changes post intervention in the biofeedback group in upper oesophageal 208 
sphincter (UES) opening (p=0.001), pharyngeal transit time (PTT) (p=0.038) and maximum 209 
hyoid displacement (p=0.033).32 Although in the remaining 8 studies design quality was 210 
poor, significant improvements were reported in functional and physiological swallowing 211 
measures.   212 
 213 
Videoendoscopy  214 
One study used videoendoscopy as a means of biofeedback.58 This involves the insertion of 215 
a flexible nasoendoscope to the level of the soft palate so that the pharynx and larynx can 216 
be visualised. The timing, safety and efficiency of the swallow can also be visualised and 217 
used for biofeedback. Denk et al taught patients to employ swallowing manoeuvres and 218 
changes in posture using videoendoscopy for direct visual biofeedback. The manoeuvres 219 
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included effortful swallow, Mendelsohn manoeuvre, supraglottic swallow and supra-supra 220 
glottic swallow depending on the nature of each participant’s dysphagia. This study met the 221 
criteria for inclusion in a meta-analysis. The control group received the same intensity of 222 
therapy and exercise type without the biofeedback. All participants were tube fed initially and 223 
73% of patients achieved therapeutic success, defined as tube removal and full and 224 
unrestricted oral intake.  At 40 days, significantly more of the biofeedback group had 225 
achieved therapeutic success (p=0.041) however there was no significant difference 226 
between the intervention and control groups at 6 months.  227 
 228 
Respiratory plethysmography  229 
One study used respiratory inductance plethysmography and nasal airflow as a method of 230 
biofeedback to train participants to adopt a natural respiration/swallow pattern.35 Nasal 231 
airflow is measured by a nasal cannula and respiratory inductance plethysmography 232 
measures movements of the ribcage and abdomen.  These devices were attached to a Kay 233 
Pentax Digital Swallowing Workstation via Swallow Signals Lab which processed the signals 234 
and presented the respiration patterns on a screen for the patients to use as feedback. They 235 
went through identification, acquisition and mastery stages to learn to swallow mid expiration 236 
with a mid to low lung volume and exhale post swallow. Significant improvements were 237 
reported with swallow physiological measures and swallow respiratory patterns but the there 238 
was no control group to compare outcomes.  239 
 240 
Quantitative synthesis 241 
Five studies had a non-confounded control group and thus met the criteria for inclusion in 242 
the meta-analysis (N=138).32, 34, 41, 44, 58 Two were excluded because two different 243 
interventions were compared.45, 55 The remaining 18 were excluded because they did not 244 
include a control group nor did they demonstrate an observational study design of sufficient 245 
quality. Study quality was variable (Table 2) with at least one element of bias evident in all of 246 
the studies. 247 
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 248 
Due to the range of outcome measures used, data from only three outcomes could be 249 
synthesized. Biofeedback did not improve swallow function (FOIS, t=2, n=51, MD=1.10; 95% 250 
CI [-1.69, 3.89], Figure 3A); or clinical outcome (feeding tube removal, t=2, n=53, OR =3.19; 251 
95% CI [0.16, 62.72], Figure 3C). Biofeedback intervention had a significant positive effect 252 
on swallow physiology, specifically hyoid displacement (t=3, n=90, MD=0.22; 95% CI [0.04, 253 
0.40], Figure 3B); two of these studies used sEMG and one used accelerometry (Table 1). 254 
There was significant statistical heterogeneity between trials in measures of swallow function 255 
and number tube fed (I2 = 70-94%) and low in physiological measures (I2 = 8%). Sub-group 256 
analyses were planned to explore effects of biofeedback type, aetiology of dysphagia, 257 
setting and dose, including assessment for publication bias, but this could not be performed 258 
due to the paucity of studies.  259 
 260 
DISCUSSION 261 
 262 
There is an absence of good quality, large-scale RCTs assessing biofeedback as an adjunct 263 
to therapy for dysphagia in adults. Meta-analysis of controlled studies showed a positive 264 
effect of biofeedback on one swallow physiology outcome; maximum displacement of the 265 
hyoid bone.  No conclusions can be drawn from other positive results in functional, 266 
physiological and clinical outcome measures reported in several small, non-randomised 267 
controlled trials.   268 
 269 
Three controlled trials found that biofeedback augmented dysphagia therapy resulted in 270 
increased hyoid displacement 32, 41, 57 when compared to a control. Two of these studies 271 
used sEMG and the other used accelerometry for biofeedback, both of which show patients 272 
a representation of hyolaryngeal elevation. Studies with healthy subjects have demonstrated 273 
that increases in sEMG amplitude correlate with onset and offset of hyoid 59 and laryngeal 274 
elevation.60 The sEMG signal represents activity predominantly from mylohyoid, anterior 275 
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belly of the digastric, and the geniohyoid muscles, confirmed using intra-muscular EMG.61 276 
sEMG amplitude increases with effortful swallowing 62 and the peak accelerometry signal 277 
correlates with peak laryngeal elevation.63 Biofeedback is used with the aim of improving 278 
timing, strength and duration of hyolaryngeal elevation. Therefore, it stands to reason that 279 
therapy targeting hyolaryngeal elevation results in corresponding physiological changes in 280 
hyoid displacement. Li et al reported functional changes in swallowing in their accelerometry 281 
study but unfortunately the other two studies did not report any data on functional outcome. 282 
Whether physiological change results in improvements in functional swallowing remains 283 
unclear. Three trials (using tongue manometry, 44 accelerometry 41 and videoendoscopy 58) 284 
reported improvement in swallow function 41, 44 and tube removal post biofeedback 285 
intervention.41, 58 However, when pooled in the meta-analysis these became neutral and non-286 
significant.  287 
 288 
These results need to be interpreted with caution since different types of biofeedback were 289 
used across studies and so heterogeneity was high. Included studies were also limited by 290 
both trial design and small sample size. For example McCullough et al used a cross over 291 
design in a heterogeneous population, a mix of subacute and chronic stroke participants, 292 
which will naturally recover at different rates.57 In addition, they did not report the time 293 
allowed for treatment wash-out (if one exists) or any data in the crossover period, hence 294 
both treatment and ‘control’ groups received the intervention. Aoki and colleagues also had 295 
unmatched groups at baseline with more severe dysphagia in the intervention group, further 296 
confounding interpretation.44 The causes of dysphagia in this trial were also mixed, hence 297 
understanding the results must be put into context of aetiology and the potential variation in 298 
response to treatment.  299 
 300 
Biofeedback might enhance recovery and improve aspiration risk in the short-term but may 301 
not lead to significant gains in the long-term. In patients with head and neck cancer, Denk 302 
reported a significant difference in means between groups at 40 days but not at the end of 303 
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the study (6 months).58 The authors suggest that biofeedback helps patients learn 304 
manoeuvres and exercises but once learnt, the biofeedback has no benefit. If so, these early 305 
gains could be beneficial for those with dysphagia secondary to multiple causes – it may 306 
mean quicker return to full normal intake, improve a patient’s quality of life, reduce morbidity, 307 
length of stay in hospital and health costs. Whether biofeedback for dysphagia is beneficial 308 
or not in both the short and long term needs further investigation. 309 
 310 
Across all the biofeedback intervention studies included in the qualitative analysis, 311 
heterogeneity in method and therapy exercise was observed, hence it is important to use 312 
appropriate outcome measures depending on the mechanism targeted. Accelerometry and 313 
sEMG biofeedback enables a representation of the strength and duration of hyolaryngeal 314 
elevation; 6 of 15 studies aimed to increase hyolaryngeal elevation32, 38, 39, 41, 50, 57 but only 315 
four measured this as an outcome.32, 41, 50, 57 The remaining studies aimed to improve 316 
swallowing skill and measured function or overall severity. Tongue manometry aims to 317 
improve lingual strength and timing; 4 of 5 studies 43, 45, 46, 64 measured this and oral control 318 
appropriately as an outcome. The study utilising respiratory plethysmography measured 319 
coordination of breathing and swallowing which is the mechanism it was targeting in 320 
therapy.35 Videoendoscopy enabled feedback should measure changes in swallow safety 321 
and efficiency and physiological changes dependent on the strategies learnt i.e. Mendelson 322 
manoeuvre targets hyolaryngeal elevation.  However, in the included study only ‘therapeutic 323 
success’ (defined as tube removal and return to full oral diet) was measured.58  324 
 325 
Biofeedback is often used in physiotherapy to augment skill based therapy and skill training 326 
results in better functional outcomes than non-specific strength training in adults post stroke  327 
65. All but one of the studies included in the qualitative synthesis used the task of swallowing 328 
as either the target exercise or one of the exercises within the therapy sessions.  This 329 
involved exercises and strategies to improve the strength, timing and/or duration of the 330 
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swallow. Further work is needed to determine whether biofeedback paired with swallow skill 331 
vs strength training results in better outcomes.  332 
 333 
It is not known if biofeedback may be better focussed on specific types of dysphagia, or 334 
whether it can be applied more generally. In the present review, only four studies included 335 
patients with a specific type of impairment that the biofeedback targeted, none of which were 336 
included in the meta-analysis. Three tongue manometry studies included patients if they had 337 
poor oral control and/or reduced lingual strength.45, 46, 64 One of the sEMG studies included 338 
patients only if they had evidence of reduced hyolaryngeal excursion.50 The remainder 339 
included patients with any type of swallowing impairment or any type of pharyngeal 340 
dysphagia. The diverse range of methods used with biofeedback provides a challenge in 341 
selecting the most appropriate technique for future studies. This will also depend on the 342 
expected natural progression of the underlying cause of dysphagia in the population studied. 343 
Defining the nature of the swallowing impairment in future studies will help to identify which 344 
patients might benefit from specific forms of biofeedback.  345 
Due to the paucity of studies, sub group analysis was not possible to investigate whether 346 
one type of biofeedback was more efficacious over others, whether specific impairments 347 
respond better to biofeedback, or the optimal dose of therapy relative to outcomes, and 348 
timing of intervention. Therefore there is insufficient evidence to guide clinicians in the use of 349 
biofeedback and its use will be dependent on the local resource. 350 
 351 
Study Limitations 352 
Several limitations should be considered when interpreting our results. Selection bias may 353 
be present but this risk was minimised by searching a range of databases and grey 354 
literature, and using two reviewers to search and select appropriate publications. Authors 355 
were contacted when information was not available in the text, although there was a limited 356 
response to these requests. Only English language studies were included which increases a 357 
risk of bias towards publications in larger English language international journals, which 358 
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possibly tend towards studies with positive results. One Chinese article with sufficient detail 359 
in an English abstract was included despite no access to the full text.32 However, there were 360 
limited methodological details available such as the means of measuring hyoid elevation and 361 
thus it was impossible to assess its full risk of bias and quality. A second limitation in 362 
interpreting this review is the paucity of good quality RCTs with blinding and transparent 363 
reporting of data. Most of the studies identified were single case studies or small studies with 364 
no control groups. There is also an absence of good quality observational or longitudinal 365 
studies which that use pre-interventional measures as a comparator. We have purposely 366 
been broad on the inclusion of studies in the meta-analysis because there are so few. It 367 
would be easy to exclude all of them on the basis of quality. Therefore, the outcomes must 368 
be interpreted with caution. For example two of the five studies in the meta- analysis had a 369 
control group that did not receive exactly the same intervention 44, 57.  The control groups in 370 
the remaining three studies received the same type and intensity of exercise – the only 371 
difference being biofeedback 32, 41, 58. Thus, the meta-analysis may not solely tell us about 372 
the augmentative effects of biofeedback per se but the effects of biofeedback paired with a 373 
variety of exercises. Third, the variety of outcome measures limited the amount of data that 374 
could be pooled in meta-analyses and some studies reported only outcomes in swallow 375 
physiology or performance on a target exercise but these do not necessarily signify 376 
meaningful change for patients.  377 
 378 
CONCLUSIONS 379 
Dysphagia therapy augmented by biofeedback seems to improve physiological outcome, 380 
specifically hyoid displacement, but whether this translates to functional improvements is not 381 
clear. However, data were obtained from small studies at high risk of bias and conclusions 382 
must be interpreted with caution. Further good quality research is required to guide whether 383 
biofeedback augmented dysphagia therapy leads to better outcomes for patients with 384 
dysphagia. Particular attention should address specific populations (aetiology and dysphagia 385 
type) with clearly defined timing of administration relative to the onset of dysphagia. Further, 386 
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the dose of swallow therapy (number, length and intensity of sessions) paired with 387 
biofeedback is unknown and should be assessed using well-designed, randomised 388 
controlled trials. Further research is also needed establishing validated and meaningful 389 
outcome measures following swallow therapy. 390 
  391 
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Figure Legends 558 
Figure 1. Search strategy for MEDLINE 559 
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Figure 3. Results from Meta-analysis (Review Manager 5.3) showing changes in A) function, 561 
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biofeedback compared to usual care.   563 
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Table 1: Summary of included studies 566 
Table 2: Risk of bias in the studies included in the meta-analysis 567 
Table 1: Summary of included studies 
Author Biofeedback 
device 
N Exercise Aetiology Intensity Frequency  Duration Outcomes 
Aoki 2015* 44 Tongue 
manometry - JMS 
34 TS and ES 23 stroke 
11 mixed 
aetiology 
45 mins 5 days/ 
week 
3 weeks Improvement in tongue strength and swallow physiology (MASA) 
post therapy, (but no significant difference between groups). 
Control group received the tongue exercises at the same intensity.  
Athukorala 2014 
51 
sEMG 10 SS Parkinson’s 
Disease (PD) 
60 mins 5 days/ 
week 
2 weeks Improvement in swallow physiology (timed swallow test and VFS) 
post therapy 
Bogaardt 2009 
36 
sEMG 11 MM Stroke 20 mins 1-2 x 
fortnight 
4-24 
weeks 
Improvement in swallow function (FOIS) and tube status post 
therapy 
Bryant 1991 53 sEMG 1 MM and ES Head & Neck 
Cancer (H&N 
Ca) 
no info 3 x week 10 weeks Subjective improvement in swallow severity and tube status 
Carnaby-Mann 
2009 & 2010 a  
55, 56 
sEMG 24 MM and ES Mixed 60 mins 5 x week up to 3 
weeks 
Improvement in swallow function (FOIS) and tube status post 
therapy (less improvement than case group) 
Crary 2004 52 sEMG 45 Fixed 
swallow 
protocol 
Mixed 50 mins 5 days/week 3-4 weeks Improvement in swallow function (FOIS) and tube status post 
therapy 
Denk, 1997* 58 Videoendoscopy 33 MM, ES, 
SGS, SSGS 
H&N Ca 45 mins 2-5 days per 
week 
up to 6 
months 
Improvement in tube status post therapy - no significant difference 
between groups at the end of the study (6 months). The control 
group received the same intensity and type of intervention without 
biofeedback.  
Felix 2008 47 External laryngeal 
manometry 
4 ES   PD no info 5 days/week 2 weeks Subjective improvement in swallow function post therapy 
Hageman DASI 
web 40 
Accelerometry 103 SS Mixed no info Unknown 3 months Improvement in Swallow Function and Pneumonia Risk scale - 
92% made average of 2-point improvement post therapy 
Haynes 1976 49 sEMG 1 Relaxation Psychogenic 
dysphagia 
30 mins 1-2 x week 11 weeks Subjective improvement in swallow function post therapy 
Huckabee 1999 
54 
sEMG 10 MM and ES, 
Shaker, 
Masako 
Brainstem 
injury 
60 mins 2 x day 5 days Improvement in swallow function (own scale) and tube status post 
therapy 
Huimin 2015* † 
32 
sEMG 36 Functional 
swallow 
training 
Stroke Unknown 6 days/week 4 weeks Improvement in swallow physiology (pharyngeal transit time, UES 
opening and maximum hyoid displacement compared to control 
group (same intervention with no biofeedback) 
Krishnan  
2013 39 
Accelerometry 1 SS with 
target 
PD 30 mins 3 x week 2 weeks Subjective improvement in oral intake post therapy 
Li 2016* 41 Accelerometry 20 SS, ES & MM 
with targets 
Stroke 60 mins 3 x week 5-6 weeks Significant improvement in hyoid displacement, function (FOIS) and 
tube status compared to control group (same intervention with no 
biofeedback) 
Li 2016 42 Accelerometry & 
sEMG 
21 SS with 
target 
Mixed 60 mins 3 x week 5 weeks Improvement in swallow function (FOIS) and tube removal post 
therapy 
Martin-Harris 
2015 35 
Airflow and 
inductance 
plethysmography 
30 Swallows on 
expiration 
H&N Ca 60 mins 2 x week up to 4 
weeks 
Improvement in swallow breathing coordination, aspiration (PAS) 
and MBS Imp sub scores post therapy (no meaningful difference in 
swallow function/QOL (MD Anderson Dysphagia Inventory)) 
McCullough 
2012 & 2013* a 
34, 57 
sEMG 18 MM  Stroke 45-60mins 2 x day 2 weeks Improvement in hyoid displacement post therapy, no improvement 
in other physiological or functional measures. Cross over design – 
intervention vs no intervention 
Reddy 2000 38 Accelerometry 5 SS, MM - 
with target 
Mixed 30 mins 1-3 x week 3-9 weeks Subjective improvement in dysphagia severity on VFS pre therapy 
Robbins  
2007 33 
Tongue 
manometry - IOPI 
10 TS   Stroke no info 3 x day/3 
days per 
week 
8 weeks Improvement in tongue strength and aspiration (PAS) post therapy 
but no or variable improvement in other physiological measures.  
Steele 2012 50 sEMG 8 SS, ES & MM 
with targets 
Mixed Unknown Unknown Unknown Improvement on swallow strength (sEMG) post therapy variable 
improvement on physiological measures 
Steele 2013 43 Tongue 
manometry - IOPI 
6 TS and ES Traumatic 
Brain Injury 
no info 2 x week 11-12 
weeks 
Improvement in tongue strength and aspiration (PAS) post therapy 
but no or variable improvement in other subjective and 
physiological measures. Worsening of residue.  
Steele 2016 45 Tongue 
manometry - IOPI 
14 TS and ES Stroke no info 2-3 x week 8-12 
weeks 
Improvement in tongue strength post therapy but no or variable 
improvement in other physiological measures pre and post therapy 
Yeates 2008 46 Tongue 
manometry - IOPI 
3 TS and ES Mixed 45 mins 2-3 x week 8-12 
weeks 
Improvement in tongue strength post therapy but variable 
improvement in other subjective and physiological measures 
* included in meta-analysis; a same data presented in both studies; † abstract data only 
MM = Mendelsohn manoeuvre; SS = saliva swallow; ES = effortful swallow; SGS = supraglottic swallow; SSGS = super supraglottic swallow; TS = tongue 
strength. 
  
 
Table 2: Risk of bias in the studies included in the meta-analysis.  
Study Suitable 
control  
Random 
sequence 
generation 
Allocation 
concealment 
Blinding of 
participants/ 
therapist  
Blinding of 
assessors 
Incomplete 
data 
Selective 
reporting 
Aoki 2015 44 + - Unknown + + + + 
Denk 1997 58 + Unknown Unknown - - - - 
Li 2016 41 + - - - - + + 
McCullough 2012 & 2013 34 + + - - + + - 
Huimin 2015 32 + + Unknown Unknown Unknown Unknown Unknown 
  + low risk of bias/good quality; - high risk of bias/poor quality 
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Figure 1. Search strategy for MEDLINE
1. exp Deglutition Disorders/
2. oropharyngeal dysphagia.mp.
3. oro-pharyngeal dysphagia.mp.
4. dysphagia.mp.
5. 'swallowing impairment'.mp.
6. deglutition disorder.mp.
7. 1 or 2 or 3 or 4 or 5 or 6
8. exp Biofeedback, Psychology/
9. biofeedback.mp.
10. Feedback, Physiological/ or Feedback/ or
Feedback, Sensory/ or Feedback, Psychological/
11. feedback.mp.
12. 'skill therapy'.mp.
13. (swallow* adj3 (therap* or exercise* or
intervention* or rehabilitat* or train*)).mp. [mp=title,
abstract, original title, name of substance word,
subject heading word, keyword heading word,
protocol supplementary concept word, rare
disease supplementary concept word, unique
identifier]
14. 8 or 9 or 10 or 11 or 12 or 13
15. exp Deglutition/
16. deglutition.mp.
17. swallow*.mp.
18. 15 or 16 or 17
19. 7 and 14 and 18
20. limit 19 to (english language and humans)
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Figure 2: Study flow diagram
Records identified through
database searching
(n = 669)
Additional records identified
through other sources
(n = 6)
Records after duplicates removed
(n = 468)
Records screened
(n = 53)
Records excluded
(n = 416)
Full-text articles assessed
for eligibility
(n = 33)
No full text = 19
Same data reported = 1
Studies included in
qualitative synthesis
(n = 23)
Studies included in
quantitative synthesis
(meta-analysis)
(n = 5)
Full-text articles excluded,
(n = 10), with reasons
No intervention = 4
No biofeedback = 6
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Figure 3. Results from Meta-analysis (Review Manager 5.3) showing changes in A) function, 
B) clinical outcome and C) physiology in patients receiving swallowing therapy with 
biofeedback compared to usual care.   
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